Title: WEBINAR: The Emergence of Digital Signatures in Clinical Operations
Date(s) And Time(s): Oct 5 2010 11:00AM - Oct 5 2010 12:30PM
Interest Area(s): Clinical Research,Regulatory Affairs,Quality Assurance/Quality Control
Overview:
The past five years have shown a dramatic growth of digital signature use in clinical applications. Regulatory compliance, expedited processes, and significant cost savings are among the many benefits that have enabled clinical organizations to gain a competitive advantage by taking their approval processes electronic.
Digital signatures enable clinical organizations to: • Create, control, and share documentation internally and externally in a trusted, compliant, and secure manner • Adhere to 21 CFR part 11, GxP audits, HIPAA, SOX, and other regulations and effectively support regulatory audits • Eliminate the hard costs of paper-based approval processes, i.e., printing, routing, archiving, etc. • Expedite processes and enhance collaboration including secure document exchange and electronic submissions
This webinar will address business benefits, technical challenges, and deployment considerations from CRO, sponsor, and SaaS/CSO perspectives based on real-world use of digital signatures in the clinical market today.
Featured Topics • Case studies of actual digital signature deployments within: - Quality, audit, and compliance operations - Site monitoring and field operations - Investigator Portals • Case studies presented on live installations at large Pharma, Medical Device, and Software-as-a-Service (SaaS) based clinical services. • Applications discussed range from quality and compliance documentation, investigator site monitor reporting, clinical trial management (CTMS) and Investigator Portal for Trial Master File forms.
Learning Objectives: At the conclusion of this webinar, participants should be able to: • Describe the business benefi ts and deployment considerations for digital signatures within clinical operations • Identify the ROI (return on investment) that digital signatures bring to clinical organizations • Explain the importance of selecting digital signature technology that complements existing infrastructure (low total cost of ownership), integrates with common business applications and end user requirements (to facilitate user adoption)
Target Audience: Professionals involved in IT, clinical informatics, clinical operations, QA and RA at: • CROs • Study sponsors • Clinical technology vendors • Site monitoring and fi eld operations • Investigator portals • Medical device companies Functional responsibilities: clinical research associates, project managers, clinical operations, quality assurance, regulatory affairs, training, IT, information security, document management, records management, validation and compliance.
Event Code: 10244
Contact Information: Questions about this Webinar? Contact Wendy Moyer at the DIA offi ce in Horsham, PA by telephone +1.215.293.5810, fax +1.215.442.6199, or email Wendy.Moyer@diahome.org.
|
|
Webinar
| Charitable Nonprofit/Acad | $175.00 | | Member Standard | $250.00 | | NonMember Standard | $295.00 | | Government (Full Time) | $125.00 | | Group Site | $799.00 | | Group Plus | $995.00 |
|
IACET: Drug Information Association has been approved as an Authorized Provider by the International Association for Continuing Education and Training (IACET), 8405 Greensboro Drive, Suite 800, McLean, VA 22102; (703) 506-3275.
Drug Information Association is authorized by IACET to offer .2 CEUs for this program.
Continuing education credits are available to learners who participate in each session of the live online course. Continuing education credits are not available for the archived sessions of the online course.
| WEBINAR: The Emergence of Digital Signatures in Cl | IACET
| 0.20
| 0.000
|
Disclosure Policy: It is Drug Information Association policy that all faculty participating in continuing education activities must disclose to the program audience (1) any real or apparent conflict(s) of interest related to the content of their presentation and (2) discussions of unlabeled or unapproved uses of drugs or medical devices. Faculty disclosures will be included in the course materials.
Statement of Credit: To request your statement of credit, please go to www.diahome.org. Select “Continuing Education” on the
left menu and select “My Transcript.” You will be prompted for your username and password which will then take you to your transcript. Select the appropriate educational activity from the grid and then choose “Credit Request” in the bottom of the right pane.
|
Minimum System Requirements:
Browser
Microsoft® Internet Explorer 5.2 or higher
Netscape® Navigator 7
Computer
166Mhz Pentium-based PC with Microsoft® Windows® 98,
NT, ME, XP or 2000
Sun JVM 1.4* for Microsoft JVM (all versions supported by
Microsoft Windows OS shown above)
Sun SPARCstation with Solaris 8 or 9
Audience: 64 MB RAM
*If you need to install Java Virtual Machine (JVM) on your system, please download it from the Sun Microsystems website.
Internet Connection Speed
56k or faster
Display
800x600 pixel resolution or greater (1024x768 pixels recommended)
Attendees using Macintosh OS
Microsoft IE 5.2
Macintosh OS 10.2X
To test your system compatibility, click on the link below.
https://diahome.webex.com/ec0605l/eventcenter/support/eventManager.do?siteurl=diahome
|
Rodd Schlerf FDA and USDA Markets Manager ARX, Inc., United States
Tim Kroboth Senior Account Executive NextDocs Corporation, United States
|
|
|